The Liver Prometastatic Reaction of Cancer Patients: Implications for Microenvironment-Dependent Colon Cancer Gene Regulation

Egeblad M, Nakasone ES, Werb Z (2010) Tumors as organs: complex tissues that interface with the entire organism. Dev Cell 18:884–901

Witz IP, Levy-Nissenbaum O (2006) The tumor microenvironment in the post-PAGET era. Cancer Letters 246:1–10

Fidler IJ (2001) Seed and soil revisited: contribution of the organ microenvironment to cancer metastasis. Surg Oncol Clin N Am 10:257–269

Paget S (1889) The distribution of secondary growths in cancer of the breast. Lancet 133:571–573

Wang HB, Dembo M, Hanks SK, Wang Y (2001) Focal adhesion kinase is involved in mechanosensing during fibroblast migration. Proc Natl Acad Sci USA 98:11295–11300

Schedin P, Keely PJ (2011) Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression. Cold Spring Harb Perspect Biol 3:a003228

Jessup JM, Laguinge L, Lin S et al (2004) Carcinoembryonic antigen induction of IL-10 and IL-6 inhibits hepatic ischemic/reperfusion injury to colorectal carcinoma cells. Int J Cancer 111:332–337

Beacham DA, Cukierman E (2005) Stromagenesis: The changing face of fibroblastic microenvironments during tumor progression. Semin Cancer Biol 15:329–341

Baeriswyl V, Christofori G (2009) The angiogenic switch in carcinogenesis. Semin Cancer Biol 19:329–337

Budhu A, Forgues M, Ye QH et al (2006) Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 10:99–111

Vidal-Vanaclocha F (2008) The prometastatic microenvironment of the liver. Cancer Microenvironment 1:113–129

Kaplan RN, Rafii S, Lyden D (2006) Preparing the “soil”: the premetastatic niche. Cancer Res 66:11089–11093

Vidal-Vanaclocha F (2011). The Tumor Microenvironment at Different Stages of Hepatic Metastasis P. Brodt (ed.), Liver Metastasis: Biology and Clinical Management, Cancer Metastasis – Biology and Treatment 16, doi: 10.1007/978-94-007-0292-9_3 , C_ Springer Science + Business Media B.V.

Herath NI, Boyd AW (2010) The role of Eph receptors and ephrin ligands in colorectal cancer. Int J Cancer 126:2003–2011

Bellam N, Pasche B (2010) Tgf-beta signaling alterations and colon cancer. Cancer Treat Res 155:85–103

Jiang Y, Kimchi ET, Staveley-O'Carroll KF et al (2009) Assessment of K-ras mutation: a step toward personalized medicine for patients with colorectal cancer. Cancer 115:3609–3617

Vidal-Vanaclocha F. Architectural and Functional Aspects of the Liver with Implications for Cancer Metastasis. P. Brodt (ed.), Liver Metastasis: Biology and Clinical Management, Cancer Metastasis – Biology and Treatment 16, doi: 10.1007/978-94-007-0292-9_2 ,C_ Springer Science + Business Media B.V. 2011.

Barbera-Guillem E, Smith I, Weiss L (1993) Cancer-cell traffic in the liver. II. Arrest, transit and death of B16F10 and M5076 cells in the sinusoids. Int J Cancer 53:298–301

Friedman SL (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134:1655–1669

Jungermann K (1986) Functional heterogeneity of periportal and perivenous hepatocytes. Enzyme 35:161–180

Parker GA, Picut CA (2005) Liver Immunobiology. Toxicol Pathol 33:52–62

McCuskey RS (1994) The hepatic microvascular system. In: Arias IM, Boyer JL, Fausto N et al (eds) The liver: biology and pathobiology. Raven Press, New York, pp 1089–1106

Oda M, Han JY, Yokomori H (2000) Local regulators of hepatic sinusoidal microcirculation: recent advances. Clin Hemorheol Microcirc 23:85–94

Barberá-Guillem E, Rocha M, Alvarez A et al (1991) Differences in the lectin-binding patterns of the periportal and perivenous endothelial domains in the liver sinusoids. Hepatology 14:131–139

Scoazec JY, Feldmann G (1994) The cell adhesion molecules of hepatic sinusoidal endothelial cells. J Hepatol 20:296–300

Seternes T, Sorensen K, Smedsrod B (2002) Scavenger endothelial cells of vertebrates: a nonperipheral leukocyte system for high-capacity elimination of waste macromolecules. Proc Natl Acad Sci USA 99:7594–7597

Seki E, Brenner DA (2008) Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 48:322–335

Arteta B, Lasuen N, Lopategi A et al (2010) Colon carcinoma cell interaction with liver sinusoidal endothelium inhibits organ-specific anti-tumor immunity via IL-1-induced mannose receptor. Hepatology 51:2172–2182

Mendoza L, Carrascal T, de Luca M et al (2001) Hydrogen peroxide mediates vascular cell adhesion molecule-1 expression from IL-18-activated hepatic sinusoidal endothelium: implications for circulating cancer cell arrest in murine liver. Hepatology 34:298–310

Vidal-Vanaclocha F, Fantuzzi G, Mendoza L et al (2000) IL-18 regulates IL-1 beta-dependent hepatic melanoma metastasis via vascular adhesion molecule-1. Proc Natl Acad Sci USA 97:734–739

Khatib AM, Auguste P, Fallavollita L et al (2005) Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis. Am J Pathol 167:749–759

Anasagasti MJ, Alvarez A, Martin JJ et al (1997) Sinusoidal endothelium release of hydrogen peroxide enhances very late antigen-4-mediated melanoma cell adherence and tumor cytotoxicity during interleukin-1 promotion of hepatic melanoma metastasis in mice. Hepatology 25:840–846

Vidal-Vanaclocha F, Amézaga C, Asumendi A et al (1994) Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases. Cancer Res 54:2667–2672

Carrascal T, Mendoza L, Vacarcel M et al (2003) Interleukin-18 binding protein reduces B16 melanoma hepatic metastasis by neutralizing the adhesiveness and growth factors of sinusoidal endothelial cell. Cancer Res 63:491–497

Vidal-Vanaclocha F, Alvarez A, Asumendi A et al (1996) Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro. J Natl Cancer Inst 88:198–205

Zubia A, Mendoza L, Vivanco S et al (2005) Application of stereocontrolled stepwise [3 + 2] Cycloadditions to the preparation of inhibitors of alpha(4)beta(1)-integrin-mediated hepatic melanoma metastasis. Angew Chem Int Ed Engl 44:2903–2907

Fausto N (2004) Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology 39:1477–1487

Smedsrød B, Le Couteur D, Ikejima K et al (2009) Hepatic sinusoidal cells in health and disease: update from the 14th International Symposium. Liver Int 29:490–501

Malik R, Selden C, Hodgson H (2002) The role of non-parenchymal cells in liver growth. Sem Cell Dev Biol 13:425–431

Ramadori G, Saile B (2004) Portal tract fibrogenesis in the liver. Lab Invest 84:153–159

Olaso E, Santisteban A, Bidaurrazaga J et al (1997) Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology 26:634–642

Olaso E, Salado C, Egilegor E et al (2003) Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis. Hepatology 37:674–685

Libbrecht L, Cassiman D, Desmet V et al (2002) The correlation between portal myofibroblasts and development of intrahepatic bile ducts and arterial branches in human liver. Liver 22:252–258

Asai K, Tamakawa S, Yamamoto M et al (2006) Activated hepatic stellate cells overexpress p75NTR after partial hepatectomy and undergo apoptosis on nerve growth factor stimulation. Liver Int 26:595–603

Li Z, Diehl AM (2003) Innate immunity in the liver. Curr Opin Gastroenterol 19:565–571

Parker GA, Picut CA (2003) Liver Immunobiology. Toxicol Pathol 33:52–62

Starzl TE, Murase N, Abu-Elmagd K et al (2003) Tolerogenic immunosuppression for organ transplantation. Lancet 361:1502–1510

Safadi R, Alvarez CE, Ohta M et al (2005) Enhanced oral tolerance in transgenic mice with hepatocyte secretion of IL-10. J Immunol 175:3577–3583

Kern M, Popov A, Kurts C et al (2010) Taking off the brakes: T cell immunity in the liver. Trends Immunol 31:311–317

Frevert U, Engelmann S, Zougbédé S et al (2005) Intravital Observation of Plasmodium berghei Sporozoite Infection of the Liver. PLoS Biol 3:1034–1046

Anttila VJ, Elonen E, Nordling S et al (1997) Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications. Clin Infect Dis 24:375–380

Beaskoetxea J, Telleria N, Del Villar A et al (2006) Identification of microenvironmentally-regulated genes of colon carcinoma cells from human hepatic metastasis. Proc Amer Assoc Cancer Res 47:4298

Murthy SM, Goldschmidt RA, Rao LN et al (1989) The influence of surgical trauma on experimental metastasis. Cancer 64:2035–2044

Murthy MS, Scanlon EF, Jelachich ML et al (1995) Growth and metastasis of human breast cancers in athymic nude mice. Clin Exp Metastasis 13:3–15

Bogden AE, Moreau J-P, Eden PA (1997) Proliferative response of human animal tumors to surgical wounding of normal tissues: Onset, duration and inhibition. Br J Cancer 75:1021–1027

Hofer SO, Shrayer D, Reichner JS et al (1998) Wound-induced tumor progression: A probable role in recurrence after tumor resection. Arch Surg 133:383–389

Nordlinger B, Guiguet M, Vaillant JC et al (1996) Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1568 patients. Cancer 77:1254–1262

Jaeck D, Bachellier P, Guiguet M et al (1997) Long-term survival following resection of colorectal hepatic metastases. Br J Surg 84:977–980

Makuuchi M, Le Thai B, Takayasu K et al (1990) Preoperative portal embolizationto increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 107:521–527

Elias D, Roche A, Vavasseur D et al (1992) Induction of hypertrophy of a small left hepatic lobe by preoperative right portal embolization, preceding extended right hepatectomy. Ann Chir 46:404–410

Azoulay D, Castaing D, Smail A et al (2000) Resection of non resectable liver metastases from colorectal cancer after percutaneous PVE. Ann Surg 231:480–486

Liu H, Zhu S (2009) Present status and future perspectives of preoperative portal vein embolization. Am J Surgery 197:686–690

Elias D, de Baere T, Roche A et al (1999) During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 86:784–788

Higgins GM, Anderson RM (1931) Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 12:186–202

Ichihashi H, Mabuchi H, Suenaga M et al (1984) Liver regeneration andtumor growth in the rat after partial hepatectomy. Jpn J Surg 14:510–514

Morimoto H, Nio Y, Imai S et al (1992) Hepatectomy accelerates the growthof transplanted liver tumor in mice. Cancer Detec Prev 16:137–147

Panis Y, Ribeiro J, Chretien Y et al (1992) Dormant liver metastases: an experimental study. Br J Surg 79:221–223

Gutman M, Singh RK, Price JE et al (1994) Accelerated growth of human colon cancer cells in nude mice undergoing liver regeneration. Invasion Metastasis 14:362–371

Asaga T, Suzuki K, Umeda M et al (1991) The enhancement of tumor growth after partial hepatectomy and the effect of sera obtained from hepatectomized rats on tumor cell growth. Jpn J Surg 21:669–675

Kokudo N, Tada K, Seki M et al (2001) Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 34:267–272

Takahara T, Xue F, Mazzone M et al (2008) Metron factor-1 prevents liver injury without promoting tumor growth and metastasis. Hepatology 47:2010–2025

Gervaz P, Pak-art R, Nivatvongs S et al (2003) Colorectal adenocarcinoma in cirrhotic patients. J Am Coll Surg 196:874–879

Melato M, Laurino L, Mucli E et al (1989) Relationship between cirrhosis, liver cancer, and hepatic metastases. An autopsy study. Cancer 64:455–459

Pereira-Lima JE, Lichtenfels E, Barbosa FS et al (2003) Prevalence study of metastases in cirrhotic livers. Hepatogastroenterology 50:1490–1495

Seymour K, Charnley RM (1999) Evidence that metastasis is less common in cirrhotic than normal liver: a systematic review of post-mortem case-control studies. Br J Surg 86:1237–1242

Uetsuji S, Yamamura M, Yamamichi K et al (1992) Absence of colorectal cancer metastasis to the cirrhotic liver. Am J Surg 164:176–177

Song E, Chen J, Ouyang N et al (2001) Kupffer cells of cirrhotic rat livers sensitize colon cancer cells to Fas-mediated apoptosis. Br J Cancer 84:1265–1271

Vanbockrijck M, Kloppel G (1992) Incidence and morphology of liver metastasis from extrahepatic malignancies to cirrhotic livers. Zentralbl Pathol 138:91–96

Qi K, Qiu H, Sun D et al (2004) Impact of cirrhosis on the development of experimental hepatic metastases by B16F1 melanoma cells in C57BL/6 mice. Hepatology 40:1144–1150

Olaso E, Ikeda K, Eng FJ et al (2001) DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. J Clin Invest 108:1369–1378

Badiola I, Olaso E, Crende O, et al (2011). Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis. Gut, in press.

Zhang LJ, Zheng WD, Chen YX et al (2007) Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis. Hepatogastroenterology 54:2092–2098

Jessup JM, Samara R, Battle P et al (2004) Carcinoembryonic antigen promotes tumor cell survival in liver through an IL-10-dependent pathway. Clin Exp Metastasis 21:709–717

Zhang B, Halder SK, Kashikar ND et al (2010) Antimetastatic role of Smad4 signaling in colorectal cancer. Gastroenterology 138:969–980

Nadal C, Maurel J, Gascon P (2007) Is there a genetic signature for liver metastasis in colorectal cancer? World J Gastroenterol 13:5832–5844

Kwon HC, Kim SH, Roh MS et al (2004) Gene expression profiling in lymph node-positive and lymph node-negative colorectal cancer. Dis Colon Rectum 47:141–152

Ki DH, Jeung HC, Park CH et al (2007) Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int J Cancer 121:2005–2012

Bertucci F, Salas S, Eysteries S et al (2004) Gene expression profi ling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 23:1377–1391

Koehler A, Bataille F, Schmid C et al (2004) Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage. J Pathol 204:65–74

Agrawal D, Chen T, Irby R et al (2002) Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94:513–521

D’Arrigo A, Belluco C, Ambrosi A et al (2005) Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma. Int J Cancer 115:256–262

Yamasaki M, Takemasa I, Komori T et al (2007) The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer. Int J Oncol 30:129–138

Fritzmann J, Morkel M, Besser D et al (2009) A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Gastroenterology 137:165–175

Del Villar A, Telleria N, Beaskoetxea J, et al (2008). Differential contribution of hepatocytes and hepatic myofibroblasts to the microenvironmental regulation of hepatic metastasis genes from colon carcinoma patients. Proc Amer Assoc Cancer Res 48:

Beaskoetxea J, Telleria N, del Villar A, et al (2009). Exposure of colon carcinoma cells to hepatic microenvironment and of hepatic cells to tumor factors promotes gene expression mimic contributing to organ tropism and metastasis development. Proc Amer Assoc Cancer Res 49:

Arumugam T, Simeone DM, Schmidt AM, Logsdon CD (2004) S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J Biol Chem 279:5059–5065

Fuentes MK, Nigavekar SS, Arumugam T et al (2007) RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways. Dis Colon Rectum 50:1230–1240

Jiang L, Lai YK, Zhang J et al (2011) Targeting S100P inhibits colon cancer growth and metastasis by lentivirus-mediated RNA interference and proteomic analysis. Mol Med. doi: 10.2119/molmed.2011.00008

Gout S, Huot J (2008) Role of Cancer Microenvironment in Metastasis: Focus on Colon Cancer. CAMI 1:69–83

Richert L, Alexandre E, Lloyd T et al (2004) Tissue collection, transport and isolation procedures required to optimise human hepatocyte isolation from waste liver surgical resections. A multi-laboratory study. Liver Int 24:371–378

Kim CH, Kim J, Kahng H, Choi EC (2007) Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma. Ann Surg Oncol 14:1565–1574

Agrawal D, Chen T, Irby R et al (2002) Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94:513–521

Pan HW, Ou YH, Peng SY et al (2003) Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma. Cancer 98:119–127

Reiniger IW, Wolf A, Welge-Lussen U et al (2007) Osteopontin as a serologic marker for metastatic uveal melanoma: results of a pilot study. Am J Ophthalmol 143:705–707

Wai PY, Mi Z, Guo H et al (2005) Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis. Carcinogenesis 26:741–751

Ma C, Rong Y, Radiloff DR et al (2008) Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev 22:308–321

Raffel J, Bhattacharyya AK, Gallegos A et al (2003) Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival. J Lab Clin Med 142:46–51

Noike T, Miwa S, Soeda J et al (2008) Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer. Hum Pathol 39:201–208

Komatsu K, Murata K, Kameyama M et al (2002) Expression of S100A6 and S100A4 in matched samples of human colorectal mucosa, primary colorectal adenocarcinomas and liver metastases. Oncology 63:192–200

Wilson JM, Coletta PL, Cuthbert RJ et al (2005) Macrophage migration inhibitory factor promotes intestinal tumorigenesis. Gastroenterology 129:1485–1503

Lee H, Rhee H, Kang HJ et al (2008) Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas. Am J Clin Pathol 129:772–779

Li M, Lin YM, Hasegawa S et al (2004) Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol 24:305–312

Okado-Matsumoto A, Matsumoto A, Fujii J, Taniguchi N (2000) Peroxiredoxin IV is a secretable protein with heparin-binding properties under reduced conditions. J Biochem 127:493–501

Tsao TY, Tsai CS, Tung JN et al (2009) Function of CSE1L/CAS in the secretion of HT-29 human colorectal cells and its expression in human colon. Mol Cell Biochem 327:163–170

Stella Tsai CS, Chen HC et al (2010) Serum cellular apoptosis susceptibility protein is a potential prognostic marker for metastatic colorectal cancer. Am J Pathol 176:1619–1628

Quaresima B, Crugliano T, Gaspari M et al (2008) A proteomics approach to identify changes in protein profiles in serum of Familial Adenomatous Polyposis patients. Cancer Lett 272:40–52

Li ZG, Zhao L, Liu L, Ding YQ (2007) Monitoring changes of serum protein markers in metastatic colorectal carcinoma model. Zhonghua Bing Li Xue Za Zhi 36:48–52

Maeda S, Hikiba Y, Sakamoto K et al (2009) Ikappa B kinasebeta/nuclear factor-kappaB activation controls the development of liver metastasis by way of interleukin-6 expression. Hepatology 50:1851–1860

Matsui H, Hikichi Y, Tsuji I et al (2003) LIGHT, a member of the tumor necrosis factor ligand superfamily, prevents tumor necrosis factor-alpha-mediated human primary hepatocyte apoptosis, but not Fas-mediated apoptosis. J Biol Chem 277:50054–50061